Comprehensive HIV and Harm Prevention Via Telehealth

Recruiting now · Not applicable

Conditions studied: HIV Infections

In brief

The purpose of this study is to test 2 different ways to offer medications to prevent human immunodeficiency virus (HIV), cure hepatitis C virus (HCV) (if applicable) and treat substance use disorder (if desired) in people who inject drugs.

Key facts

Study ID

NCT05897099

Run by

University of Miami

People needed

350

Starts

2024-10-07

Expected to finish

2028-05-31

Last updated by the study team

2026-02-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• age 18 or older
• able to speak English or Spanish
• willing and able to sign informed consent, provide locator information and medical records release
• non-reactive result on rapid HIV test
• use of SSP to exchange syringes 2 times in the past 3 months
• planning to stay in the area for 12 months

You may not qualify if…

• reactive HIV test
• currently on medications for opioid use disorder (MOUD) by urine drug screen
• currently on PrEP by self-report
• Principal or site investigator discretion
• currently in prison or jail
• current enrollment in Clinical Trials Network 121
• receipt of tele-harm reduction in previous 3 months
• signs or symptoms of acute HIV infection

Where it is running

• IDEA Miami — Miami, Florida, United States (enrolling)
• IDEA Syringe Services Program — Miami, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.